Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

The Gateses Foot Bill for Polio Vaccine

By Drug Discovery Trends Editor | May 12, 2016

 This partnership could help enable the switch between oral polio vaccines to the Sabin-strain inactive poliovirus vaccines in an effort to keep samples of the virus before it’s eradicated.The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.

Takeda will use this financing to “develop, license, and supply at least 50 million doses per year of so-called Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries,” according to Reuters.

Rajeev Venkaya, the head of Takeda’s vaccines unit, told Reuters that the Gates grant would “de-risk the investment” needed to advance this vaccine candidate through the last phase of clinical trials, licensing deals, and then putting it on the market. Venkayya added that the vaccine candidate has completed mid-stage Phase 2 trials, but the firm needs to do more work when it comes to development and testing.

READ MORE: Takeda’s Tools for Fighting Infectious Diseases

Gavi, a global alliance for vaccines and immunizations, will work with the World Health Organization and similar entities to ensure the injection is available at affordable prices in these countries.

Ultimately, this partnership could help enable the switch between oral polio vaccines to the Sabin-strain inactive poliovirus vaccines in an effort to keep samples of the virus before it’s eradicated.

A total of 12 cases of polio, which causes damaging paralysis, were recorded in Pakistan and Afghanistan in 2016 so far. Reuters explained global experts have said stopping all polio transmissions is possible by the end of the year whereas another report theorizes the total global eradication of this disease could occur by the end of the decade. 

 

R&D 100 AWARD ENTRIES NOW OPEN:

Establish your company as a technology leader! For more than 50 years, the R&D 100 Awards have showcased new products of technological significance. You can join this exclusive community! Learn more.


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE